449 related articles for article (PubMed ID: 26671136)
21. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test.
Sepulcre J; Vanotti S; Hernández R; Sandoval G; Cáceres F; Garcea O; Villoslada P
Mult Scler; 2006 Apr; 12(2):187-95. PubMed ID: 16629422
[TBL] [Abstract][Full Text] [Related]
22. Screening for memory problems in multiple sclerosis.
Dent A; Lincoln NB
Br J Clin Psychol; 2000 Sep; 39(3):311-5. PubMed ID: 11033753
[TBL] [Abstract][Full Text] [Related]
23. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
[TBL] [Abstract][Full Text] [Related]
24. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
Lazeron RH; Boringa JB; Schouten M; Uitdehaag BM; Bergers E; Lindeboom J; Eikelenboom MI; Scheltens PH; Barkhof F; Polman CH
Mult Scler; 2005 Oct; 11(5):524-31. PubMed ID: 16193889
[TBL] [Abstract][Full Text] [Related]
25. Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function.
Hansen S; Muenssinger J; Kronhofmann S; Lautenbacher S; Oschmann P; Keune PM
Clin Neuropsychol; 2017 Jan; 31(1):179-192. PubMed ID: 27707354
[TBL] [Abstract][Full Text] [Related]
26. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
27. The brief repeatable battery of neuropsychological tests: normative values allow application in multiple sclerosis clinical practice.
Boringa JB; Lazeron RH; Reuling IE; Adèr HJ; Pfennings L; Lindeboom J; de Sonneville LM; Kalkers NF; Polman CH
Mult Scler; 2001 Aug; 7(4):263-7. PubMed ID: 11548987
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
[TBL] [Abstract][Full Text] [Related]
29. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
[TBL] [Abstract][Full Text] [Related]
30. [Correlation between olfactory dysfunction and various clinical parameters in patients with multiple sclerosis].
Kostić J; Stefanova E; Pekmezović T; Drulović J
Vojnosanit Pregl; 2009 Mar; 66(3):203-6. PubMed ID: 19341225
[TBL] [Abstract][Full Text] [Related]
31. [Neuropsychological tests in multiple sclerosis].
Takeda A
Nihon Rinsho; 2014 Nov; 72(11):1989-94. PubMed ID: 25518382
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.
Cáceres F; Vanotti S; Rao S;
J Clin Exp Neuropsychol; 2011 Dec; 33(10):1094-8. PubMed ID: 21978317
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of cognitive functions in gestational diabetes mellitus.
Keskin FE; Ozyazar M; Pala AS; Elmali AD; Yilmaz B; Uygunoglu U; Bozluolcay M; Tuten A; Bingöl A; Hatipoglu E
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):246-51. PubMed ID: 25868060
[TBL] [Abstract][Full Text] [Related]
34. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
35. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
36. Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.
Akbar N; Honarmand K; Kou N; Feinstein A
J Neurol; 2011 Mar; 258(3):373-9. PubMed ID: 20924594
[TBL] [Abstract][Full Text] [Related]
37. The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed.
Berrigan LI; LeFevre JA; Rees LM; Berard JA; Francis A; Freedman MS; Walker LAS
Mult Scler Relat Disord; 2022 Dec; 68():104229. PubMed ID: 36279599
[TBL] [Abstract][Full Text] [Related]
38. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Strober L; Chiaravalloti N; Moore N; DeLuca J
Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
[TBL] [Abstract][Full Text] [Related]
39. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
40. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
